Aprea Therapeutics, Inc.
Pharmaceutical Preparations · Doylestown, PA, United States
- PrincipalsJohn P. HamillSrVP/CFO/Prin Fin & Acct OfcrOren GiladPresident/CEOand 1 more
- CompanyAprea Therapeutics, Inc.Doylestown, PA, United States
- Phone line+1 (215) 948-4119General business
Aprea Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker APRE) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 3
Chief executive
Oren GiladPresident/CEO
Chair & board
Marc DueyDirector (Board)
Finance
John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗John P. Hamill — SrVP/CFO/Prin Fin & Acct Ofcr
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Oren Gilad — President/CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Marc Duey — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Amneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityAmarin Corp PLC\UKPharmaceutical Preparations · Dublin 21 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capabilityCannapharmarx, Inc.Pharmaceutical Preparations · Mountain View County1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capability